期刊
LEUKEMIA & LYMPHOMA
卷 47, 期 2, 页码 313-314出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/10428190500271723
关键词
JAK2; mutation; non-Hodgkin lymphoma; oncogene
Recently, the JAK2 V617F mutation has been reported in high proportions of chronic myeloproliferative disorders, including polycythemia vera. To see whether the JAK2 V617F is important in the pathogenesis of lymphoid malignancies, this study analysed the occurrence of the JAK2 V617F mutation in 117 non-Hodgkin lymphomas (NHLs) by a single strand conformation polymorphism assay. However, there was no JAK2 V617F mutation in the NHLs and the data suggest that the JAK2 V617F mutation may not play a role in the development of NHL.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据